News

In the control arm, 43% of patients crossed over to receive Trodelvy monotherapy after disease progression, representing 81% of those who received any subsequent treatment following chemo-Keytruda, ...
All eyes are on Munich on Saturday night where the Champions League final will be decided between Inter and PSG. We look at ...
Figure out how to beat Nightreign's deadly ice dragon with this guide.
An international clinical trial shows an innovative CAR-T cell immunotherapy is promising against aggressive T cell cancers and has manageable side effects.
There have been important recent advances in the management of Crohn's disease, including new classes of biological or small molecule therapies, an appreciation that endoscopic mucosal healing results ...
One of the toughest challenges in the base campaign of Xenoblade Chronicles X might just be the intimidating boss of Chapter ...
Fort Cavazos leaders are moving forward with the implementation of the Army’s Deferred Resignation Programs while remaining ...
A SpaceX launch of a GPS satellite Friday marked the latest national security mission taken away from United Launch Alliance ...
Regeneron and Sanofi face setbacks as itepekimab stumbles in phase 3. Click here to read why I believe SNY and REGN stocks ...
Sempra's Port Arthur Phase 2 project in Texas has won U.S. approval to export liquefied natural gas to markets in Europe and ...
JD.com is testing a fiat-pegged stablecoin in Hong Kong’s regulatory sandbox for cross-border payments and retail use.